摘要 |
The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them. |
申请人 |
AXYS PHARMACEUTICALS, INC.;GRAUPE, MICHAEL;LAU, AGNES, J.;LI, JIAYAO;LINK, JOHN, O.;MOSSMAN, CRAIG, J.;WOO, SOON, H.;ZIPFEL, SHEILA, M. |
发明人 |
GRAUPE, MICHAEL;LAU, AGNES, J.;LI, JIAYAO;LINK, JOHN, O.;MOSSMAN, CRAIG, J.;WOO, SOON, H.;ZIPFEL, SHEILA, M. |